市場調查報告書

中國的醫藥品流通產業:2019年∼2026年

China Pharmaceutical Distribution Industry Report, 2019-2026

出版商 ResearchInChina 商品編碼 933892
出版日期 內容資訊 英文 140 Pages
商品交期: 最快1-2個工作天內
價格
中國的醫藥品流通產業:2019年∼2026年 China Pharmaceutical Distribution Industry Report, 2019-2026
出版日期: 2020年04月30日內容資訊: 英文 140 Pages
簡介

中國的醫藥品流通市場近幾年順利擴大,2019年成為與前一年同期比較增加8.9%的2兆3,303億元,其中醫藥品零售市場達到了年率增加9.9%的4,661億元。預計旺盛的下游需求刺激中國的醫藥品流通市場成長,2026年成為4兆2,257億元的規模。

本報告提供中國的醫藥品流通產業調查分析,產業概要,產業的發展,藥局連鎖前100家分析,並包含主要企業簡介等內容。

第1章 醫藥品流通產業概要

  • 定義
  • 產業鏈
  • 醫藥品連鎖企業的優勢和弱點

第2章 中國的醫藥品流通產業

  • 發展環境
  • 現狀
  • 市場規模
  • 市場結構
  • 競爭環境
  • 發展趨勢

第3章 中國的醫藥品零售市場

  • 銷售規模
  • 商店數
  • 毛利率、淨利率
  • 數量
    • 前100名藥局連鎖
    • 線上藥局
    • 獨立型藥局
    • 藥局的新開張、停業的比例
  • 醫療保險的適用範圍
  • 每1客戶的交易

第4章 主要企業

  • China National Accord Medicines Corporation Ltd.
  • Nanjing Pharmaceutical Co., Ltd.
  • Shanghai No.1 Pharmacy Co., Ltd.
  • China National Medicines Corporation Ltd.
  • Huadong Medicine Co., Ltd.
  • Cachet Pharmaceutical Co., Ltd.
  • Jointown Pharmaceutical Group Co., Ltd.
  • Realcan Pharmaceutical Co., Ltd.
  • Shanghai Pharmaceuticals Holding Co., Ltd.
  • Zhejiang Int'l Group Co., Ltd.
  • Zhejiang Zhenyuan Share Co., Ltd.
  • China Meheco Co., Ltd.
  • Charmacy Pharmaceutical Co., Ltd.
  • Luyan Pharma Co., Ltd.
  • China Resources Pharmaceutical Group Limited
  • DaShenLin Pharmaceutical Group Co., Ltd.
目錄

The Chinese pharmaceutical distribution market has been expanding steadily over the recent years, being valued at RMB2,330.3 billion in 2019 with a year-on-year increase of 8.9%, of which the pharmaceutical retail market reached RMB466.1 billion, rising 9.9% on an annualized basis. The robust downstream demand spurs the Chinese pharmaceutical distribution market to grow apace and be expectedly worth RMB4,225.7 billion by 2026.

Western medicine sales dominate pharmaceutical distribution in China, accounting for 72.2% in 2018; the sales in East China and Central South China seize larger shares up to 62.1% together in 2018.

A competition pattern has been developed in the country where there are national pharmaceutical distributors represented by China National Pharmaceutical Group Corporation (Sinopharm), China Resources Pharmaceutical Commercial Group, Shanghai Pharmaceuticals and Jointown Pharmaceutical Group and the regional ones represented by NanJing Pharmaceutical, Guangzhou Pharmaceuticals, Chongqing Pharmaceutical, Huadong Medicine, Sichuan Kelun, Zhejiang Int'l, Realcan Pharmaceutical, Guangxi Liuzhou Pharmaceutical Co., Ltd. and Luyan Pharma Co., Ltd.

As of end of November 2018, there had been 13,598 pharmaceutical wholesalers nationwide which competed fiercely in the scattered market. The market tends to be concentrated with the incentive policies such as the two-invoice system and volume procurement. As to earnings, China National Pharmaceutical Group Corp. still led the pack and Shanghai Pharmaceuticals Holding Co., Ltd. ascended to the second place, while China Resources Pharmaceutical Commercial Group Co., Ltd. dropped a notch and ranked third. It is worth mentioning that the commercial segment of Shenzhen Neptunus Galaxy Pharmaceutical Investment Co., Ltd. reported the revenue of RMB36,976 million in 2018 (compared with just RMB64.48 million in 1998), an upsurge of 54.33% from a year earlier, helping it rise to the sixth place among Chinese pharmaceutical wholesale enterprises.

A total of 5,671 pharmaceutical retail chain enterprises in China as of the end of 2018 were in possession of 255,467 stores; 52.2% of pharmacies had been chained, a year-on-year increase of 1.7 percentage points; pharmacies covered by medical insurance had shared 72%.

The leading drug retail chains in China mainly include Yixintang , Dashenlin , LBX Pharmacy, Yifeng Pharmacy, Sinopharm , Nepstar , Zhongyou Health, Quanyi Health, Tong Jun Ge, Jianzhijia, to name a few. In 2018, the total sales of the top 100 Chinese pharmaceutical retail enterprises posted RMB143,982.52 million as a percentage of 33.4% in the total. Sinopharm, the largest pharmaceutical retail enterprise in China, secured the sales of RMB12250.53 million in 2018, equivalent to 2.8% of the total.

Huge potentials of the pharmaceutical distribution industry has lured investors and frequent M&As occurred over the recent years. With the in-rush of capital, pharmaceutical distribution companies are heading from traditional endogenous growth (such as adding products, developing customers and opening new stores) to the extensional growth like mergers and acquisitions, and the industry is increasingly concentrated.

Highlights of the report:

Pharmaceutical distribution industry in China (development environment, status quo, market size/structure, competitive landscape, development trends, etc.);

Chinese pharmaceutical retail market (market size, gross margin, net profit margin, quantity, ratio of pharmacies covered by medical insurance, per customer transaction, performance comparison of leading pharmaceutical retail companies);

16 Chinese pharmaceutical distributors (profile, operation, revenue structure, gross margin, development strategy, etc.).

Table of Contents

1. Overview of Pharmaceutical Distribution Industry

  • 1.1 Definition
  • 1.2 Industry Chain
  • 1.3 Strength and Weakness of Pharmaceutical Chain Enterprises
    • 1.3.1 Strength of Pharmaceutical Chain Enterprises
    • 1.3.2 Weakness of Pharmaceutical Chain Enterprises

2. Pharmaceutical Distribution Industry in China

  • 2.1 Development Environment
    • 2.1.1 Policy
    • 2.1.2 Economy
    • 2.1.3 Medical Institution
    • 2.1.4 Health Expenditure
    • 2.1.5 Aging
    • 2.1.6 Per Capita Disposable Income
  • 2.2 Status Quo
  • 2.3 Market Size
  • 2.4 Market Structure
  • 2.5 Competitive Landscape
  • 2.6 Development Trends
    • 2.6.1 Pharmaceutical E-commerce Becomes an Important Model
    • 2.6.2 Capital Market Plays a Bigger Role in Integration of Enterprises
    • 2.6.3 Favorable Policies Push up Market Concentration
    • 2.6.4 Growing Trend towards Regionalization
    • 2.6.5 Wholesale-retail Integration Spurs Industry Consolidation
    • 2.6.6 Prescription Leaks Facilitate the Industry
    • 2.6.7 Individual Pharmacies Withdraw, while Chain Pharmacies Prevail
    • 2.6.8 The Thriving Pharmaceutical O2O

3 Chinese Drug Retail Market

  • 3.1 Market Size
  • 3.2 Gross Margin and Net Profit Margin
  • 3.3 Quantity
    • 3.3.1 Top100 Pharmacy Chains
    • 3.3.2 Online Pharmacy
    • 3.3.3 Independent Pharmacy
    • 3.3.4 Proportion of Pharmacies Newly Opened and Closed
  • 3.4 Coverage of Medical Insurance
  • 3.5 Per Customer Transaction

4. Major Enterprises

  • 4.1 China National Accord Medicines Corporation Ltd.
    • 4.1.1 Profile
    • 4.1.2 Operation
    • 4.1.3 Revenue Structure
    • 4.1.4 Gross Margin
    • 4.1.5 Pharmaceutical Distribution Business
    • 4.1.6 Development Strategy
  • 4.2 Nanjing Pharmaceutical Co., Ltd.
    • 4.2.1 Profile
    • 4.2.2 Operation
    • 4.2.3 Revenue Structure
    • 4.2.4 Gross Margin
    • 4.2.5 Pharmaceutical Distribution Business
    • 4.2.6 Development Strategy
  • 4.3 Shanghai No.1 Pharmacy Co., Ltd.
    • 4.3.1 Profile
    • 4.3.2 Operation
    • 4.3.3 Revenue Structure
    • 4.3.4 Gross Margin
    • 4.3.5 Development Strategy
  • 4.4 China National Medicines Corporation Ltd.
    • 4.4.1 Profile
    • 4.4.2 Operation
    • 4.4.3 Revenue Structure
    • 4.4.4 Gross Margin
  • 4.4.5Pharmaceutical Distribution Business
    • 4.4.6 Development Strategy
  • 4.5 Huadong Medicine Co., Ltd.
    • 4.5.1 Profile
    • 4.5.2 Operation
    • 4.5.3 Revenue Structure
    • 4.5.4 Gross Margin
    • 4.5.5 Pharmaceutical Distribution Business
    • 4.5.6 Development Strategy
  • 4.6 Cachet Pharmaceutical Co., Ltd.
    • 4.6.1 Profile
    • 4.6.2 Operation
    • 4.6.3 Revenue Structure
    • 4.6.4 Gross Margin
    • 4.6.5 Pharmaceutical Distribution Business
    • 4.6.6 Development Strategy
  • 4.7 Jointown Pharmaceutical Group Co., Ltd.
    • 4.7.1 Profile
    • 4.7.2 Operation
    • 4.7.3 Revenue Structure
    • 4.7.4 Gross Margin
    • 4.7.5 Pharmaceutical Distribution Business
    • 4.7.6 Development Strategy
  • 4.8 Realcan Pharmaceutical Co., Ltd.
    • 4.8.1 Profile
    • 4.8.2 Operation
    • 4.8.3 Revenue Structure
    • 4.8.4 Gross Margin
    • 4.8.5 Pharmaceutical Distribution Business
    • 4.8.6 Development Strategy
  • 4.9 Shanghai Pharmaceuticals Holding Co., Ltd.
    • 4.9.1 Profile
    • 4.9.2 Operation
    • 4.9.3 Revenue Structure
    • 4.9.4 Gross Margin
    • 4.9.5 Pharmaceutical Distribution Business
    • 4.9.6 Development Strategy
  • 4.10 Zhejiang Int'l Group Co., Ltd.
    • 4.10.1 Profile
    • 4.10.2 Operation
    • 4.10.3 Revenue Structure
    • 4.10.4 Gross Margin
    • 4.10.5 Pharmaceutical Distribution Business
    • 4.10.6 Development Strategy
  • 4.11 Zhejiang Zhenyuan Share Co., Ltd.
    • 4.11.1 Profile
    • 4.11.2 Operation
    • 4.11.3 Revenue Structure
    • 4.11.4 Gross Margin
    • 4.11.5 Pharmaceutical Distribution Business
    • 4.11.6 Development Strategy
  • 4.12 China Meheco Co., Ltd.
    • 4.12.1 Profile
    • 4.12.2 Operation
    • 4.12.3 Revenue Structure
    • 4.12.4 Gross Margin
    • 4.12.5 Pharmaceutical Distribution Business
    • 4.12.6 Development Strategy
  • 4.13 Charmacy Pharmaceutical Co., Ltd.
    • 4.13.1 Profile
    • 4.13.2 Operation
    • 4.13.3 Revenue Structure
    • 4.13.4 Gross Margin
    • 4.13.5 Pharmaceutical Distribution Business
    • 4.13.6 Development Strategy
  • 4.14 Luyan Pharma Co., Ltd.
    • 4.14.1 Profile
    • 4.14.2 Operation
    • 4.14.3 Revenue Structure
    • 4.14.4 Gross Margin
    • 4.14.5 Pharmaceutical Distribution Business
    • 4.14.6 Development Strategy
  • 4.15 China Resources Pharmaceutical Group Limited
    • 4.15.1 Profile
    • 4.15.2 Operation
    • 4.15.3 Revenue Structure
    • 4.15.4 Gross Margin
    • 4.15.5 Pharmaceutical Distribution Business
    • 4.15.6 Development Strategy
  • 4.16 DaShenLin Pharmaceutical Group Co., Ltd.
    • 4.16.1 Profile
    • 4.16.2 Operation
    • 4.16.3 Revenue Structure
    • 4.16.4 Gross Margin
    • 4.16.5 Pharmaceutical Distribution Business
    • 4.16.6 Development Strategy

Selected Charts

China Pharmaceutical Distribution Channel

Difference between Pure Marketing and Allocation in China's Pharmaceutical Distribution

Policies on China's Pharmaceutical Distribution Industry, 2016-2020

China's GDP, 2012-2019

Number of Medical and Healthcare Institutions in China, 2015-2019

Number of Hospitals in China, 2009-2019

Number of Hospitals in China by Economic Type, 2009-2019

Health Expenditure in China, 2010-2019

Health Expenditure in China, 2018-2025E

Population Aged over 65 in China, 2009-2025E

Residents' Per-capita Disposable Income and YoY Growth in China, 2011-2019

Promotion and Implementation of the Two-Invoice Policy

Pharmaceutical Distribution Market Size and YoY Growth in China, 2006-2019

Pharmaceutical Distribution Market Size and YoY Growth in China, 2019-2026E

Pharmaceutical Distribution Sales Structure in China by Type, 2018

Pharmaceutical Distribution Sales Structure in China by Region, 2018

Pharmaceutical Distribution Revenue in China by Region, 2018

Top 20 Pharmaceutical Distribution Companies in China by Operating Revenue, 2017-2018

Revenue of Major Pharmaceutical Distribution Companies in China, 2013-2019

Net Income of Major Pharmaceutical Distribution Companies in China, 2013-2019

Pharmaceutical Distribution Revenue of Major Pharmaceutical Distribution Companies in China, 2013-2019

Total Sales of Pharmaceutical E-commerce Direct Reporting Enterprises (Which Are Recommended by the Local Competent Authority and Confirmed by the Ministry of Commerce and Then are Included in the Direct Designated Statistics) (without Certificate A) in China, 2015-2018

Capital Layout of China's Pharmaceutical Retail Industry in Recent Years

China's Tier-1 and Tier-2 Capital Investment in Pharmacies by Region

Regulatory Policies Prompt the Concentration of Retail Pharmacy Market in China, 2015-2019

Representative Pharmaceutical Distribution Enterprises in China by Regional Market

Policies for Prescription Outflow in China, 2015-2018

Top 10 Pharmacies in China by Prescription Drug Sales, 2018

BATJ's Layout in Pharmaceutical O2O Platforms in China

Drug Retail Market Size and YoY Growth in China, 2012-2019

Drug Retail Market Size and YoY Growth in China, 2019-2026E

Average Gross Margin of Sample Pharmacies in China by Value, 2010-2019

Average Net Margin of Sample Pharmacies in China by Value, 2010-2019

Number of Drug Retail Chains in China, 2012-2018

Drug Retail Chains in China by Number of Stores, 2012-2018

Number of Independent Retail Drugstores in China, 2012-2018

Pharmaceutical Retail Chain Ratio in China, 2009-2018

Top 100 Pharmacy Chains in China by Total Revenue, 2018

Top 100 Pharmacy Chains via Direct Sales Mode in China, 2019

Top 50 Online Pharmacies in China, 2019

Top 30 Independent Pharmacies in China by Revenue, 2018

Proportion of New Pharmacies in China, 2014-2018

Enterprises Whose New Pharmacies Made up over 30% in China, 2018

Average Investment in a Pharmacy in China, 2014-2018

Proportion of Closed Pharmacies in China, 2014-2018

Enterprises Whose Closed Pharmacies Made up over 5% in China, 2018

Proportion of Pharmacies Covered by Medical Insurance in China, 2014-2018

Enterprises Owning 600 Pharmacies Covered by Medical Insurance in China, 2018

Enterprises Whose 95% Pharmacies Were Covered by Medical Insurance in China, 2018

Per Customer Transaction of Pharmacies in China, 2013-2018

Enterprises Whose Pharmacies Secured the Per Customer Transaction over RMB135 in China, 2018

Revenue and Net Income of China National Accord Medicines, 2013-2019

Revenue Breakdown of China National Accord Medicines by Business, 2015-2019

Gross Margin of China National Accord Medicines' Main Business, 2016-2019

Number of Stores of China National Accord Medicines, as of the end of June 2019

O2O Platform Sales of China National Accord Medicines, 2019H1

Revenue and Net Income of Nanjing Pharmaceutical, 2013-2019

Revenue Breakdown of Nanjing Pharmaceutical by Business, 2015-2019

Revenue Breakdown of Nanjing Pharmaceutical by Region, 2015-2019

Gross Margin of Nanjing Pharmaceutical by Business, 2015-2019

Revenue and Net Income of Shanghai No.1 Pharmacy, 2013-2019

Revenue Breakdown of Shanghai No.1 Pharmacy by Business, 2014-2019

Revenue Structure of Shanghai No.1 Pharmacy by Business, 2014-2019

Gross Margin of Shanghai No.1 Pharmacy, 2016-2019

Gross Margin of Shanghai No.1 Pharmacy by Business, 2014-2018

Revenue and Net Income of China National Medicines, 2013-2019

Revenue Breakdown of China National Medicines by Business, 2014-2019

Revenue Structure of China National Medicines by Business, 2014-2019

Revenue Breakdown of China National Medicines by Region, 2014-2019

Revenue Structure of China National Medicines by Region, 2014-2019

Gross Margin of China National Medicines, 2014-2019

Gross Margin of China National Medicines by Business, 2014-2019

Revenue and Net Income of Huadong Medicine, 2013-2019

Revenue Breakdown of Huadong Medicine by Sector, 2014-2019

Revenue Structure of Huadong Medicine by Sector, 2014-2019

Gross Margin of Huadong Medicine by Sector, 2014-2019

Revenue and Net Income of Cachet Pharmaceutical, 2013-2019

Revenue Breakdown of Cachet Pharmaceutical by Business, 2014-2019

Revenue Structure of Cachet Pharmaceutical by Business, 2014-2019

Revenue Breakdown of Cachet Pharmaceutical by Region, 2014-2019

Revenue Structure of Cachet Pharmaceutical by Region, 2014-2019

Gross Margin of Cachet Pharmaceutical's Pharmaceutical Wholesale Business, 2014-2019

Revenue and Net Income of Jointown Pharmaceutical Group, 2013-2019

Revenue Breakdown of Jointown Pharmaceutical Group by Business, 2014-2019

Revenue Structure of Jointown Pharmaceutical Group by Business, 2014-2019

Gross Margin of Jointown Pharmaceutical Group by Business, 2014-2019

Main Pharmaceutical Products Wholesaled by Jointown Pharmaceutical Group

Revenue and Net Income of Realcan Pharmaceutical, 2013-2019

Revenue Breakdown of Realcan Pharmaceutical by Business, 2014-2019

Revenue Structure of Realcan Pharmaceutical by Business, 2014-2019

Gross Margin of Realcan Pharmaceutical by Business, 2014-2019

Revenue and Net Income of Shanghai Pharmaceuticals Holding, 2013-2019

Revenue Breakdown of Shanghai Pharmaceuticals Holding by Business, 2014-2019

Revenue Structure of Shanghai Pharmaceuticals Holding by Business, 2014-2019

Revenue Breakdown of Shanghai Pharmaceuticals Holding by Region, 2014-2019

Gross Margin of Shanghai Pharmaceuticals Holding by Business, 2014-2019

Revenue and Net Income of Zhejiang Int'l Group, 2013-2019

Revenue Breakdown of Zhejiang Int'l Group by Business, 2017-2019

Gross Margin of Zhejiang Int'l Group's Pharmaceutical Sales Business, 2016-2019

Revenue and Net Income of Zhejiang Zhenyuan, 2013-2019

Revenue Breakdown of Zhejiang Zhenyuan by Business, 2014-2019

Revenue Structure of Zhejiang Zhenyuan by Business, 2014-2019

Gross Margin of Zhejiang Zhenyuan by Business, 2014-2019

Revenue and Net Income of China Meheco, 2013-2019

Revenue Breakdown of China Meheco by Business, 2014-2019

Revenue Structure of China Meheco by Business, 2014-2019

Gross Margin of China Meheco by Business, 2014-2019

Revenue and Net Income of Charmacy Pharmaceutical, 2013-2019

Revenue Breakdown of Charmacy Pharmaceutical by Product/Client, 2013-2019

Revenue Structure of Charmacy Pharmaceutical by Product/Client, 2013-2019

Gross Margin of Charmacy Pharmaceutical, 2013-2019

Luyan Pharma's Investment Projects with Raised Funds by Initial Public Offerings

Revenue and Net Income of Luyan Pharma, 2013-2019

Revenue Breakdown of Luyan Pharma by Business, 2014-2019

Revenue Structure of Luyan Pharma by Business, 2014-2019

Gross Margin of Luyan Pharma's Pharmaceutical Wholesale Business, 2014-2019

Revenue and Net Income of China Resources Pharmaceutical Group, 2013-2019

Revenue Breakdown of China Resources Pharmaceutical Group by Business, 2013-2019

Revenue Structure of China Resources Pharmaceutical Group by Business, 2013-2019

Gross Margin of China Resources Pharmaceutical Group, 2013-2019

Development Strategy of China Resources Pharmaceutical Commercial Group Co., Ltd., 2020

Revenue and Net Income of DaShenLin Pharmaceutical, 2014-2019

Revenue Breakdown of DaShenLin Pharmaceutical by Business, 2014-2018

Revenue Structure of DaShenLin Pharmaceutical by Business, 2014-2018

Gross Margin of DaShenLin Pharmaceutical, 2013-2018